MAPT and Alzheimer disease: The authors reported that forced expression of SET in the brain of rats decreased PP2A activity, and it induced abnormal hyperphosphorylation of tau, neurodegeneration, spatial reference memory and memory consolidation, deficits typical of AD [121].